Paul Abernathy - Aug 13, 2025 Form 4 Insider Report for NATIONAL HEALTHCARE CORP (NHC)

Role
Director
Signature
/s/ J. Paul Abernathy
Stock symbol
NHC
Transactions as of
Aug 13, 2025
Transactions value $
$100
Form type
4
Date filed
8/15/2025, 04:29 PM
Previous filing
May 9, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
ABERNATHY JAMES PAUL Director 1523 MIRABELLA WAY, MURFREESBORO /s/ J. Paul Abernathy 2025-08-15 0001261687

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NHC Shares of Common Stock Options Exercise $287K +4.01K +11.45% $71.64 39K Aug 13, 2025 Direct F1
transaction NHC Shares of Common Stock Tax liability -$287K -2.64K -6.76% $108.82 36.4K Aug 13, 2025 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NHC Option to Purchase Common Stock [2021 Grant] Options Exercise $0 -4.01K -100% $0.00 0 Aug 13, 2025 Common Stock 4.01K $71.64 Direct F1
holding NHC Option to Purchase Common Stock [2022 Grant] 7.5K Aug 13, 2025 Common Stock 7.5K $69.19 Direct
holding NHC Option to Purchase Common Stock [2023 Grant] 7.5K Aug 13, 2025 Common Stock 7.5K $55.75 Direct
holding NHC Option to Purchase Common Stock [2024 Grant] 7.5K Aug 13, 2025 Common Stock 7.5K $96.03 Direct
holding NHC Option to Purchase Common Stock [2025 Grant] 7.5K Aug 13, 2025 Common Stock 7.5K $94.66 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 6, 2021. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
F2 Shares were withheld by the Company to pay the exercise price.
F3 Total amount of shares beneficially owned following transactions reported on this form.